Evidence map›Paper›PMID 37323439›Full record

ReviewRSC advances2023

Surface modified nanoparticles and their applications for enantioselective detection, analysis, and separation of various chiral compounds.

Susanti, Asep Riswoko, Joddy Arya Laksmono, Galuh Widiyarti, Dadan Hermawan

Abstract readReview
In one paragraph

Review in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

SusantiResearch Center for Polymer Technology - National Research and Innovation Agency (BRIN) KST BJ. Habibie, Kawasan Puspiptek Building 460 Tangerang Selatan 15314 Indonesia asep022@brin.go.id.ORCID https://orcid.org/0000-0002-5529-8268
Asep RiswokoResearch Center for Polymer Technology - National Research and Innovation Agency (BRIN) KST BJ. Habibie, Kawasan Puspiptek Building 460 Tangerang Selatan 15314 Indonesia asep022@brin.go.id.ORCID https://orcid.org/0000-0001-7773-5572
Joddy Arya LaksmonoResearch Center for Polymer Technology - National Research and Innovation Agency (BRIN) KST BJ. Habibie, Kawasan Puspiptek Building 460 Tangerang Selatan 15314 Indonesia asep022@brin.go.id.ORCID https://orcid.org/0000-0003-0664-1645
Galuh WidiyartiResearch Center for Pharmaceutical Ingredients and Traditional Medicine - National Research and Innovation Agency (BRIN) KST BJ Habibie, Kawasan Puspiptek Building 452 Tangerang Selatan 15314 Indonesia.ORCID https://orcid.org/0000-0002-0235-596X
Dadan HermawanDepartment of Chemistry, Faculty of Mathematics and Natural Science, Jenderal Soedirman University (UNSOED) Indonesia.ORCID https://orcid.org/0000-0003-1483-0163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of efficient enantioselective detection, analysis, and separation relies significantly on molecular interaction. In the scale of molecular interaction, nanomaterials have a significant influence on the performance of enantioselective recognitions. The use of nanomaterials for enantioselective recognition involved synthesizing new materials and immobilization techniques to produce various surface-modified nanoparticles that are either encapsulated or attached to surfaces, as well as layers and coatings. The combination of surface-modified nanomaterials and chiral selectors can improve enantioselective recognition. This review aims to offer engagement insights into the production and application of surface-modified nanomaterials to achieve sensitive and selective detection, better chiral analysis, and separation of numerous chiral compounds.

Identifiers

PMID37323439
PMCPMC10267673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.